- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Ubonratchathani Cancer Hospital
I alt 9814 resultater
-
Massachusetts General HospitalM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Dana-Farber...AfsluttetIkke småcellet lungekræftForenede Stater
-
Korea Cancer Center HospitalAsan Medical Center; Seoul National University Hospital; Gangnam Severance...RekrutteringLivmoderhalskræftKorea, Republikken, Kina, Thailand, Vietnam
-
Saitama Medical University International Medical...National Cancer Center, Japan; Tokyo University; Cancer Institute Hospital... og andre samarbejdspartnereAktiv, ikke rekrutterendeLivmoderhalskræftJapan
-
German Cancer Research CenterUniversity Hospital Heidelberg; University Hospital DresdenIkke rekrutterer endnuRecidiverende/refraktær akut myeloid leukæmi (AML)Tyskland
-
Massachusetts General HospitalM.D. Anderson Cancer Center; National Cancer Institute (NCI)Aktiv, ikke rekrutterendeKordoma af Sacrum | Chordoma af Rygsøjlen | Chordom af Skallebasis | Chondrosarkom i rygsøjlen | Chondrosarcoma of the SacrumForenede Stater
-
Barretos Cancer HospitalUniversity of Campinas, Brazil; AC Camargo Cancer CenterUkendtAdenocarcinom | Kolorektale neoplasmerBrasilien
-
University Hospital HeidelbergGerman Cancer Research Center; University Hospital DresdenAktiv, ikke rekrutterendeEsophageale neoplasmer | Gastrisk Adenocarcinom | Esophageal Adenocarcinom | Gastroøsofageal Junction Adenocarcinom | Mave-neoplasmaTyskland
-
University Hospital HeidelbergGerman Cancer Research Center; University Hospital DresdenAfsluttetLeukæmi, Myeloid, AkutTyskland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Massachusetts General HospitalAktiv, ikke rekrutterendeSpiserørskræftForenede Stater
-
Massachusetts General HospitalM.D. Anderson Cancer Center; National Cancer Institute (NCI)Aktiv, ikke rekrutterendeHjerne svulst | Medulloblastom | PineoblastomForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Massachusetts General HospitalAfsluttetLungekræftForenede Stater
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Adelphi University; Queen's Hospital CenterAfsluttetUndersøgelse | Risikoopfattelse | Kræftrelaterede risici | FokusgruppeForenede Stater
-
Zhejiang Cancer HospitalIkke rekrutterer endnu
-
Henan Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekrutteringOmfattende stadie af småcellet lungekræftKina
-
Henan Cancer HospitalRekrutteringIkke-pladeeplade ikke-småcellet lungekræftKina
-
Fujian Cancer HospitalIkke rekrutterer endnu
-
Fujian Cancer HospitalRekrutteringEndetarmssygdomme | StrålingsskaderKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnu
-
Henan Cancer HospitalRekrutteringAkut myeloid leukæmi | Thalidomid | Vedligeholdelsesbehandling | Mindre restsygdom | Interferon-a-lb | Interleukin-2 | Venentoclax | AzacitidinKina
-
Fujian Cancer HospitalIkke rekrutterer endnu
-
Zhejiang Cancer HospitalRekruttering
-
Fujian Cancer HospitalIkke rekrutterer endnuMR | Livmoderhalskræft | Strålebehandling | Prognostisk modelKina
-
Fujian Cancer HospitalIkke rekrutterer endnu
-
Henan Cancer HospitalIkke rekrutterer endnuAvanceret brystkræft | Behandling | HR lav/HER2 negativ
-
Zhejiang Cancer HospitalIkke rekrutterer endnu
-
Fujian Cancer HospitalIkke rekrutterer endnu
-
Fujian Cancer HospitalIkke rekrutterer endnuLivmoderhalskræft | Strålebehandling | Risikofaktor | Prognostisk model | FjernmetastaseKina
-
Fujian Cancer HospitalIkke rekrutterer endnuNasopharyngealt karcinomKina
-
Zhejiang Cancer HospitalRekrutteringCholangiocarcinom | GaldevejssvulstKina
-
Zhejiang Cancer HospitalRekrutteringMavekræft | Peritoneale metastaser | Ascites, ondartetKina
-
Fujian Cancer HospitalIkke rekrutterer endnuLivmoderhalskræftKina
-
Hunan Cancer HospitalIkke rekrutterer endnuBrystkræft | Endokrin terapi | CDK4/6-hæmmere | Efterfølgende behandling
-
Zhejiang Cancer HospitalRekrutteringRituximab, Lenalidomid, Zebutinib, MantelcellelymfomKina
-
Zhejiang Cancer HospitalRekrutteringSund og rask | MavekræftKina
-
Hubei Cancer HospitalRekrutteringBrystkræft | Implantat brystrekonstruktion | Neoadjuverende strålebehandlingKina
-
Zhejiang Cancer HospitalRekrutteringHepatocellulært karcinomKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuAvanceret tyktarmskræftKina
-
Fujian Cancer HospitalIkke rekrutterer endnuGastrointestinale tumorer
-
Zhejiang Cancer HospitalRekrutteringHepatocellulært karcinom | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | PharmorubicinKina
-
Henan Cancer HospitalRekrutteringBrystkræft | HER2-positiv brystkræftKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuGaldevejskræft
-
Zhejiang Cancer HospitalIkke rekrutterer endnuHepatocellulært karcinom
-
Zhejiang Cancer HospitalRekrutteringSmåcellet lungekræft i omfattende stadieKina
-
Zhejiang Cancer HospitalRekrutteringNasopharyngealt karcinomKina
-
Hubei Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekruttering
-
Fujian Cancer HospitalIkke rekrutterer endnuLunge Adenocarcinom | PD-1 inhibitor | Stadie IV Ikke-småcellet lungekræft | VEGF
-
Fujian Cancer HospitalIkke rekrutterer endnuNSCLC | EGFR | Tredje generation af TKI